VulnerabilityModified
CVE-2023-25438
An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files.
HIGH 7.8EPSS 2.09%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (2.09%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 2.09% probability · 81th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-732
- Affected
- genomedics/millegpg
- Source
- cve@mitre.org
References
- https://millegpg.it/Vendor Advisory
- https://packetstormsecurity.com/files/172052/MilleGPG5-5.9.2-Local-Privilege-Escalation.htmlThird Party Advisory, VDB Entry
- https://millegpg.it/Vendor Advisory
- https://packetstormsecurity.com/files/172052/MilleGPG5-5.9.2-Local-Privilege-Escalation.htmlThird Party Advisory, VDB Entry
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.